Shenzhen Hepalink Pharmaceutical Group Co., Ltd.

Other Affiliated Sites

At Media Center

You Can Access Our Press Releases

Hepalink's Enoxaparin Sodium Injection Approved in Cambodia, Expanding Global Access Footprint to 79 Countries and Regions

(Shenzhen, May 13, 2026) – Shenzhen Hepalink Pharmaceutical Group Co., Ltd. ("Hepalink") today announced that enoxaparin sodium injection, manufactured by its subsidiary Shenzhen Techdow Pharmaceutical Co., Ltd. ("Techdow"), has received approval in Cambodia, further expanding the market access o...

第一页上一页 8 9 10 11 12 下一页最后一页

站点地图